PEDEVCO Announces its Participation in the 2026 EnerCom Denver – The Energy Investment Conference

HOUSTON, Aug. 14, 2026 (GLOBE NEWSWIRE) — PEDEVCO Corp. (NYSE American: PED) (“PEDEVCO” or the “Company”), a domestic energy company engaged in the acquisition and development of strategic oil and gas assets in the Rocky Mountain region, today announced that the management team will participate in the 2026 EnerCom Denver – The Energy Investment Conference taking place August 18–19, 2026.

Members of management will host investor meetings on-site during the conference. An updated investor presentation is available on the Company’s website at https://www.pedevco.com/investors.

To request a meeting with the PEDEVCO team, please reach out to your EnerCom representative or the Company’s investor relations team at [email protected].

Full event details are listed below.

2026 EnerCom Denver

Denver, Colorado
August 18-19, 2026

About PEDEVCO Corp.

PEDEVCO Corp. (NYSE American: PED) is a publicly traded energy company engaged in the acquisition and development of strategic oil and gas assets in the Rocky Mountain region. The Company’s principal assets include its D-J Basin assets in southeastern Wyoming and northern Colorado, its Powder River Basin assets in northeastern Wyoming, and its Permian Basin assets in eastern New Mexico, collectively representing over 300,000 net acres. PEDEVCO is headquartered in Houston, Texas. More information about PEDEVCO can be found at www.pedevco.com.

Media Contact:

PEDEVCO Corp.
(713) 221-1768
[email protected]

Investor Relations Contact:

Sean Mansouri, CFA or Laurent Weil
Elevate IR
(720) 330-2829
[email protected]



Crowd Street Announces Availability of Flexible Credit Income Fund from Oak Hill Advisors, Further Expanding Investment Opportunities for Members

The addition builds on Crowd Street’s funds catalogue, reinforcing commitments to private market access for eligible self-directed investors

NEW YORK, Aug. 14, 2026 (GLOBE NEWSWIRE) — Crowd Street, a private market investment platform providing investors with access to private market investment opportunities, today announced the launch of T. Rowe Price OHA Flexible Credit Income Fund “OFLEX” (Ticker: OFLAX) on its platform.

With this addition, Crowd Street expands its catalog of funds, further broadening the scope of investment opportunities available to accredited investors. The fund, representing $250M in net asset value as of June 30, 2026, opens the door to private and public credit for self-directed investors, an option that, historically, has been more commonly associated with institutional portfolios and Class A shares are now available directly to accredited investors for the first time.

“As interest and demand for private market investment strategies continue, we need to ensure that Crowd Street is offering its members a variety of investment opportunities that can help meet their needs,” said John Imbriglia, CEO of Crowd Street. “In partnering with T. Rowe Price to bring this fund to our platform, Crowd Street members now have access to yet another professionally managed strategy from a globally-recognized firm. Now, investors have a way to evaluate credit strategies that may otherwise be difficult to access directly.”

With $112 billion assets under management, Oak Hill Advisors shares Crowd Street’s commitment to creating access for self-directed investors for strategies historically associated with institutional portfolios. OFLEX is a multi-strategy investment approach that provides a single point of entry into the broad alternative credit universe, with the flexibility to invest in private and public credit markets. OFLEX marks the continued partnership of T. Rowe Price and OHA as they expand their alternative investment capabilities globally.   

“Multi-strategy credit investing has been core to OHA’s DNA since inception,” said Glenn August, Founder & Chief Executive Officer of OHA. “OFLEX is built to seek to capitalize on our best ideas across the OHA platform, applying a consistent investment process and a rigorous focus on risk management as we pursue stable, income-generating investments across both liquid and private credit markets.”

To date, Crowd Street has expanded its platform’s suite of funds to seven, including recently launched strategies with Stepstone, Nuveen, and Neuberger. With the addition of OHA to this roster, Crowd Street members can further access a growing number of professionally managed funds.

T. Rowe Price OHA Flexible Credit Income Fund “OFLEX”

The T. Rowe Price OHA Flexible Credit Income Fund “OFLEX” (Ticker: OFLAX) is a registered investment vehicle that provides individual investors with access to a mix of credit-focused opportunities across both privately negotiated and publicly traded markets. The portfolio spans several areas of the credit market, including senior direct loans, subordinated financing, asset-backed investments, structured products, and other opportunistic credit transactions. The fund is designed to give investors exposure to strategies more commonly associated with institutional portfolios.

The portfolio takes a flexible approach to allocating capital with a strategy that spans different market cycles and economic conditions. The fund operates as a continuously offered interval fund and provides monthly distributions, although payment amounts and timing are determined by the board and are not assured. Distributions are also not guaranteed and may be funded from sources other than investment income, as described in the fund’s offering documents.

While access to the private market industry expands, Crowd Street remains committed to educating investors so they can make more informed, self-directed investment decisions. To support this need, Crowd Street has introduced a new Education Center to help investors better navigate the private markets, launched financial literacy initiatives in New York and Pittsburgh, and hosted a dedicated educational series with investment consultant Callan.

As part of its commitment to investor education, Crowd Street has published resources on private market investing, including a Guide to Private Equity Investing and a Guide to Private Credit Investing. These guides provide general educational information about these asset classes, including key considerations for accredited investors. These materials are for informational purposes only and do not constitute investment advice.

For more information, visit https://crowdstreet.com/.

About Crowd Street

Crowd Street provides eligible, self-directed investors access to self-directed private market investments. The platform offers a marketplace of alternative investment opportunities that have historically primarily been available to a small group of people. In addition to providing tools, research, and insights to help investors confidently explore these available opportunities, Crowd Street is also building a member experience rooted in trust and experience – helping eligible investors evaluate private market opportunities through a self-directed platform.

Like all private market and credit investments, OFLEX involves risks, including loss of principal, limited liquidity, credit risk, market risk, and risks associated with privately negotiated investments. Investors should review the fund’s offering documents carefully before investing.

This press release is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any security. It is not investment advice, a recommendation, or a statement about the suitability of any investment for any person. Any offering is made only pursuant to the applicable offering documents, which should be reviewed carefully, including the discussion of risks, fees, expenses, and investment limitations. Private market investments are speculative, involve risk, including possible loss of principal, and may be illiquid. Availability of any investment opportunity is subject to investor eligibility requirements and applicable law. Consider the investment objectives, risks, and charges and expenses carefully before investing. For a prospectus containing this and other information, call 1-800-541-5299 or visit 


www.troweprice.com


.

About Oak Hill Advisors
Oak Hill Advisors (OHA) is a leading global credit-focused alternative asset manager with over 30 years of investment experience. OHA works with institutions and individuals and seeks to implement credit strategies across market environments. OHA manages approximately $112 billion of assets across credit strategies, including private credit, high yield bonds, leveraged loans, stressed and distressed debt and collateralized loan obligations as of March 31, 2026. OHA’s emphasis on long-term partnerships with companies, sponsors and other partners provides access to a proprietary opportunity set, allowing for customized credit solutions across market cycles. With over 400 experienced professionals, OHA brings a collaborative approach to offering investors a single platform to meet their diverse credit needs.

About T. Rowe Price

T. Rowe Price is a global investment management firm that provides a range of investment advisory, retirement, and wealth management services to individual investors, financial professionals, institutions, and intermediaries. Founded in 1937, the firm manages assets across equities, fixed income, multi-asset, and alternative investment strategies, with a focus on active management and long-term investing. T. Rowe Price emphasizes fundamental research, disciplined risk management, and client-focused decision-making, with a philosophy centered on helping investors pursue long-term financial objectives over time.

Media Contact

LaunchSquad
[email protected]



Kaplan Fox Notifies Alignment Healthcare, Inc. (NASDAQ: ALHC) Investors of an Investigation into Potential Securities Law Violations

NEW YORK, Aug. 14, 2026 (GLOBE NEWSWIRE) — Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. (“Alignment Healthcare” or the “Company”) (NASDAQ: ALHC).

CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION

If you are an Alignment Healthcare investor and have suffered losses, or if you have information that could assist in the Alignment Healthcare investigation, you may

CLICK HERE

to contact us. You may also contact Kaplan Fox by emailing

[email protected]

or by calling (646) 315-9003.

On July 8, 2026, news emerged that a former Alignment Healthcare executive had filed a whistleblower complaint alleging the Company engaged in “accounting irregularities” that “artificially inflated” Alignment Healthcare’s previously reported and projected financial results, including “Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (“Adjusted EBITDA”), a key non-GAAP financial metric central to the Company’s reported financial performance and executive compensation structure.” According to the lawsuit “millions of dollars in operating expenses had been systematically misclassified as capital expenditures.”

Following this news, on July 8, 2026, the price of Alignment Healthcare stock fell $4.02 per share, or 16.7%, to close at $20.03 per share.

WHY CONTACT KAPLAN FOX?

Kaplan Fox & Kilsheimer LLP is a nationally recognized law firm focused on complex litigation, with offices in New York, Oakland, Los Angeles, Chicago, and New Jersey. Founded in 1956, the firm has spent more than 50 years prosecuting securities, antitrust, and consumer protection actions in federal and state courts nationwide, recovering more than $10 billion for clients and the classes it has represented.

Kaplan Fox is widely regarded as one of the nation’s premier plaintiffs’ securities litigation firms and has received recognition from Chambers and Partners, Benchmark Litigation, Super Lawyers, and Lawdragon. Serving as lead or co-lead counsel in many landmark cases, the firm has secured some of the largest recoveries in the history of securities litigation, including a $2.425 billion recovery on behalf of Bank of America shareholders in In re Bank of America—the largest recovery ever obtained for claims under Section 14(a) of the Securities Exchange Act—$800 million recovered for the Arkansas Teacher Retirement System and other pension funds in ATRS v. Allianz Global Investors, and a $475 million settlement in In re Merrill Lynch.

For decades, Kaplan Fox has represented public pension funds, institutional investors, businesses, and individuals in high-stakes litigation. Through its successful advocacy and precedent-setting victories, the firm has helped shape important areas of securities and corporate law while advancing accountability and protecting investor interests.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Past results do not guarantee future outcomes.

If you have any questions about this investigation, please contact:

CONTACT:

Pamela A. Mayer
KAPLAN FOX & KILSHEIMER LLP
800 Third Avenue, 38th Floor
New York, New York 10022
(646) 315-9003
[email protected]

Laurence D. King
KAPLAN FOX & KILSHEIMER LLP
1999 Harrison Street, Suite 1501
Oakland, California 94612
(415) 772-4704
[email protected]

Contacting or submitting information to Kaplan Fox & Kilsheimer LLP does not create an attorney-client relationship, nor an obligation on the part of Kaplan Fox to retain you as a client.

https://www.kaplanfox.com/case/alignment-healthcare-investigation-learn-more/



Lowey Dannenberg P.C., Court-Appointed Co-Lead Counsel, Is Prosecuting Securities Class Action Against Ramaco Resources Inc. (NASDAQ: METC)

NEW YORK, Aug. 14, 2026 (GLOBE NEWSWIRE) — Lowey Dannenberg P.C. (“Lowey”), a preeminent law firm representing consumers and investors is prosecuting a securities class action against Ramaco Resources, Inc. (“Ramaco” or the “Company”) (NASDAQ: METC) on behalf of investors who purchased Ramaco securities between July 31, 2025 and October 23, 2025 (the “Class Period”). The case, In re Ramaco Resources, Inc. Securities Litigation, No. 1:26-cv-00846-ER, is pending in the U.S. District Court for the Southern District of New York. The case centers on Ramaco’s Brook Mine project in Sheridan, Wyoming, which the company touted to investors as a commercially and technologically feasible source of rare earth elements and critical minerals, particularly scandium.

Lowey is actively seeking investors and entities that purchased or otherwise acquired Ramaco’s common stock pursuant and/or traceable to the Company’s August 7, 2025 secondary public offering (“Secondary Offering”), which occurred during the Class Period. “As lead counsel, we are actively pursuing this case on behalf of the class, and we are looking for investors who bought in Ramaco’s Secondary Offering,” said Vincent R. Cappucci Jr., Attorney at Lowey Dannenberg, P.C. “We encourage Ramaco Secondary Public Offering Investors, as well as anyone who purchased Ramaco securities during the Class Period, to check their eligibility and contact our firm to discuss their options.”

If you invested in Ramaco’s common stock in connection with the Secondary Offering, or otherwise purchased or acquired Ramaco securities during the Class Period, and wish to discuss your rights, contact Andrea Farah ([email protected]) at (914) 733-7256 or Vincent R. Cappucci Jr. ([email protected]) at (914) 733-7278. You can also visit our website for more information.

This description is a summary of allegations in a pending lawsuit; the allegations have not been proven, and Ramaco has denied wrongdoing.

About Lowey Dannenberg

Lowey Dannenberg is a national firm representing institutional and individual investors, who suffered financial losses resulting from corporate fraud and malfeasance in violation of federal securities and antitrust laws. The firm has significant experience in prosecuting multi-million-dollar lawsuits and has recovered billions of dollars on behalf of its clients.

Attorney Advertising

Contact:

Lowey Dannenberg P.C.
44 South Broadway, Suite 1100
White Plains, NY 10601
Email: [email protected]
SOURCE: Lowey Dannenberg P.C.



Kaplan Fox Alerts Investors of Pentair plc (NYSE: PNR) with Significant Losses to a Securities Class Action Deadline on October 2, 2026

NEW YORK, Aug. 14, 2026 (GLOBE NEWSWIRE) — Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Pentair plc (“Pentair” or the “Company”) (NYSE: PNR) on behalf of investors that purchased or otherwise acquired Pentair securities between April 28, 2026 and July 14, 2026 (the “Class Period”).

CLICK HERE TO JOIN THE CASE

If you are an investor in Pentair and have suffered losses, you may

CLICK HERE

to contact us. You may also contact Kaplan Fox by emailing

[email protected]

or by calling (646) 315-9003.

DEADLINE REMINDER: If you are a member of the proposed Class, you may move the court no later than October 2, 2026 to serve as a lead plaintiff for the purported class. If you have losses we encourage you to contact us to learn more about the lead plaintiff process. You need not seek to become a lead plaintiff in order to share in any possible recovery.

The complaint alleges that on July 14, 2026, after the market closed, Pentair released its preliminary second quarter 2026 financial results, disclosing that “the [C]ompany estimates that the destocking of inventory in the Pool channel negatively impacted Pool segment sales by approximately $170 million and Pool segment income by approximately $105 million.” The Company also announced the departure of its Chief Financial Officer, effective immediately. On July 15, 2026, Pentair’s stock price fell $11.35, or 15%, to close at $64.33 per share.

WHY CONTACT KAPLAN FOX?

Kaplan Fox & Kilsheimer LLP is a nationally recognized law firm focused on complex litigation, with offices in New York, Oakland, Los Angeles, Chicago, and New Jersey. Founded in 1956, the firm has spent more than 50 years prosecuting securities, antitrust, and consumer protection actions in federal and state courts nationwide, recovering more than $10 billion for clients and the classes it has represented.

Kaplan Fox is widely regarded as one of the nation’s premier plaintiffs’ securities litigation firms and has received recognition from Chambers and Partners, Benchmark Litigation, Super Lawyers, and Lawdragon. Serving as lead or co-lead counsel in many landmark cases, the firm has secured some of the largest recoveries in the history of securities litigation, including a $2.425 billion recovery on behalf of Bank of America shareholders in In re Bank of America—the largest recovery ever obtained for claims under Section 14(a) of the Securities Exchange Act—$800 million recovered for the Arkansas Teacher Retirement System and other pension funds in ATRS v. Allianz Global Investors, and a $475 million settlement in In re Merrill Lynch.

For decades, Kaplan Fox has represented public pension funds, institutional investors, businesses, and individuals in high-stakes litigation. Through its successful advocacy and precedent-setting victories, the firm has helped shape important areas of securities and corporate law while advancing accountability and protecting investor interests.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Past results do not guarantee future outcomes.

If you have any questions about this Notice, your rights, or your interests, please contact:

CONTACT:

Pamela A. Mayer
KAPLAN FOX & KILSHEIMER LLP
800 Third Avenue, 38th Floor
New York, New York 10022
(646) 315-9003
[email protected]

Laurence D. King
KAPLAN FOX & KILSHEIMER LLP
1999 Harrison Street, Suite 1501
Oakland, California 94612
(415) 772-4704
[email protected]

Contacting or submitting information to Kaplan Fox & Kilsheimer LLP does not create an attorney-client relationship, nor an obligation on the part of Kaplan Fox to retain you as a client.

https://www.kaplanfox.com/case/pentair-plc-investor-alert-learn-more-now/



Daré Bioscience Announces Pricing of $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

SAN DIEGO, Aug. 14, 2026 (GLOBE NEWSWIRE) — Daré Bioscience, Inc. (Nasdaq: DARE), a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising science and real-world solutions, today announced that it has entered into a definitive securities purchase agreement with institutional investors for the purchase and sale of 4,379,581 shares of the Company’s common stock (or pre-funded warrants to purchase shares of common stock in lieu thereof), at a price of $1.37 per share of common stock (or $1.3699 per pre-funded warrant) in a registered direct offering priced at-the-market under Nasdaq rules. Each pre-funded warrant will be exercisable upon issuance at an exercise price of $0.0001 per share and will expire when exercised in full.

In addition, in a concurrent private placement, the Company will issue to the investors Series A warrants to purchase in the aggregate up to 4,379,581 shares of common stock, and Series B warrants to purchase in the aggregate up to 4,379,581 shares of common stock (or pre-funded warrants to purchase shares of common stock in lieu thereof). The exercisability of both the Series A warrants and the Series B warrants will be subject to obtaining stockholder approval as may be required under Nasdaq rules. The Series A warrants will have an exercise price of $1.37 per share, will be exercisable on or after stockholder approval, and will have a term of five years from the initial exercise date. The Series B warrants will have an exercise price of $1.37 per share, will be exercisable on or after stockholder approval, and will have a term of two years from the initial exercise date.

The aggregate gross proceeds to the Company from the registered direct offering at the closing are expected to be $6.0 million before deducting placement agent fees and estimated offering expenses payable by the Company.

The closing of the registered direct offering and the concurrent private placement is expected to occur on or about August 17, 2026, subject to the satisfaction of customary closing conditions.

Ladenburg Thalmann & Co. Inc. is acting as exclusive placement agent for the offerings.

The securities described above (excluding the Series A warrants, Series B warrants, and the shares of common stock underlying the Series A warrants and Series B warrants) are being offered pursuant to a shelf registration statement on Form S-3 (File No. 333-278380), which was declared effective by the United States Securities and Exchange Commission (“SEC”) on May 10, 2024. The registered direct offering is being made only by means of a prospectus, including a prospectus supplement, which is part of the effective registration statement, that will be filed with the SEC. Electronic copies of the final prospectus supplement and accompanying prospectus may be obtained, when available, on the SEC’s website at http://www.sec.gov or by contacting Ladenburg Thalmann & Co. Inc., Prospectus Department, 640 Fifth Avenue, 4th Floor, New York, New York 10019 or by email at [email protected].

The Series A warrants and Series B warrants, along with the shares of common stock underlying such warrants, are being offered in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the “Act”), and Regulation D promulgated thereunder and have not been registered under the Act, or applicable state securities laws. Accordingly, the Series A warrants and Series B warrants and the underlying shares of common stock may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Act and such applicable state securities laws.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sales of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.

ABOUT DARÉ BIOSCIENCE, INC.

Daré Bioscience (NASDAQ: DARE) is a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising science and real-world solutions. Every innovation Daré advances is based in advanced science and backed by rigorous, peer-reviewed research. From contraception to menopause, sexual health to fertility, vaginal health to infectious disease, Daré is working to close critical gaps in care using science that serves her needs. For decades, women have been told to “wait it out” or “live with it,” while innovations that could improve their quality of life languish in the regulatory or funding pipeline. With growing awareness around menopause, sexual health, and vaginal health, the conversation is shifting. However, access to proven solutions is lagging. Daré is working to change that. Learn more at darebioscience.com.

Forward-Looking Statements

Daré cautions you that all statements, other than statements of historical facts, contained in this press release, are forward-looking statements. Forward-looking statements, in some cases, can be identified by terms such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “design,” “intend,” “expect,” “could,” “plan,” “potential,” “predict,” “seek,” “should,” “would,” “contemplate,” “project,” “target,” “objective,” or the negative version of these words and similar expressions. In this press release, forward-looking statements include, but are not limited to, statements relating to timing, size, terms and completion of the offerings. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Daré’s actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by the forward-looking statements in this press release, including, without limitation, risks and uncertainties related to the timing, size, terms and completion of the offerings. Daré’s forward-looking statements are based upon its current expectations and involve assumptions that may never materialize or may prove to be incorrect. All forward-looking statements are expressly qualified in their entirety by these cautionary statements. For a detailed description of Daré’s risks and uncertainties, you are encouraged to review its documents filed with the SEC including Daré’s recent filings on Form 8-K, Form 10-K and Form 10-Q. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date on which they were made. Daré undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law.

For further information, please contact:

Daré Bioscience Investor Relations

[email protected]

Source: Daré Bioscience, Inc.



Ameren Corporation Directors Declare Quarterly Dividend

PR Newswire

ST. LOUIS, Aug. 14, 2026 /PRNewswire/ — The board of directors of Ameren Corporation (NYSE: AEE) today declared a quarterly cash dividend on its common stock of 75 cents per share. This dividend is payable Sept. 30, 2026, to shareholders of record at the close of business on Sept. 8, 2026. 

Ameren Logo

Separately, the board of directors of Union Electric Company, doing business as Ameren Missouri, declared regular quarterly cash dividends on all classes of Union Electric Company’s preferred stock. These preferred stock dividends are payable Nov. 15, 2026, to shareholders of record at the close of business on Oct. 15, 2026.

In addition, the board of directors of Ameren Illinois Company, doing business as Ameren Illinois, declared regular quarterly cash dividends on all classes of Ameren Illinois Company’s preferred stock. These preferred stock dividends are payable Nov. 1, 2026, to shareholders of record at the close of business on Oct. 9, 2026. 

About Ameren Corporation

St. Louis-based Ameren Corporation powers the quality of life for 2.5 million electric customers and more than 900,000 natural gas customers in a 64,000-square-mile area through its Ameren Missouri and Ameren Illinois rate-regulated utility subsidiaries. Ameren Illinois provides electric transmission and distribution service and natural gas distribution service. Ameren Missouri provides electric generation, transmission and distribution services, as well as natural gas distribution service. Ameren Transmission Company of Illinois develops, owns and operates rate-regulated regional electric transmission projects in the Midcontinent Independent System Operator, Inc. For more information, visit Ameren.com, or follow us at @AmerenCorpFacebook.com/AmerenCorp, or LinkedIn.com/company/Ameren

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ameren-corporation-directors-declare-quarterly-dividend-302852009.html

SOURCE Ameren Corporation

Kaplan Fox Alerts Futu Holdings Limited (NASDAQ: FUTU) Investors Who Suffered Losses to a Securities Class Action – Deadline is August 25, 2026

NEW YORK, Aug. 14, 2026 (GLOBE NEWSWIRE) — Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Futu Holdings Limited (“Futu” or the “Company”) (NASDAQ: FUTU) on behalf of investors that purchased or otherwise acquired Futu shares between May 24, 2023 and May 27, 2026 (the “Class Period”).

CLICK HERE TO JOIN THE CASE

If you are an investor in Futu and have suffered losses, you may

CLICK HERE

to contact us. You may also contact Kaplan Fox by emailing

[email protected]

or by calling (646) 315-9003.

DEADLINE REMINDER: If you are a member of the proposed Class, you may move the court no later than August 25, 2026 to serve as a lead plaintiff for the purported class. If you have losses we encourage you to contact us to learn more about the lead plaintiff process. You need not seek to become a lead plaintiff in order to share in any possible recovery.

According to the complaint, on May 22, 2026, before the market opened, Reuters published an article reporting that the China Securities Regulatory Commission (“CSRC”), along with seven other government agencies including the central bank, had launched a crackdown aimed at “brokers it accused of illegally moving money to foreign markets” including “overseas firms and their local partners operating without approval.” The article allegedly reported that online brokers including Futu “would be penalised for soliciting business in China without an onshore licence, the securities regulator said.”

Also on May 22, 2026, Futu disclosed in a press release that it had received a Notification Letter from the CSRC. The Company reported the letter states “certain Futu entities in mainland China and Hong Kong (the “Related Companies”) without obtaining the requisite licenses or approval, conducted securities business, public fund sales business and futures business in mainland China.” The press release further states that the CSRC “proposes to order the Related Companies to rectify or cease such activities, confiscate illegal gains, and impose fines, with the total proposed penalty amounting to approximately RMB1.85 billion (approximately USD271 million).”

On May 22, 2026, the price of Futu shares fell $34.10 per share, or 27.5%, to close at $89.76 per share.

Then, on May 28, 2026, before the market opened, Futu announced in a press releasee financial results for the first quarter of 2026. According to the complaint, the Company reported net income of HK$831.0 million (US$106.0 million) after giving effect to the proposed penalties comprised of: “(i) confiscation of illegal gains of approximately RMB470 million [approximately $69.21 million USD], and (ii) imposition of fines of approximately RMB1.38 billion, [approximately $20 billion USD] in an aggregate amount of approximately RMB1.85 billion.”

On May 28, 2026, the price of Futu shares fell $5.31 per share, or 4.8%, to close at $104.91 per share.

The complaint alleges, among other things, that throughout the Class Period, Defendants failed to disclose to investors that (1) Futu was not in compliance with the requirements of the CSRC, including because the Company continued to conduct securities business, public fund sales business and futures business in mainland China without obtaining the requisite licenses or approval; (2) as a result, Futu was reasonably likely to face regulatory penalties, including the disgorgement of ill-gotten gains and other penalties; and (3) as a result of the foregoing, Futu’s financial results were overstated.

WHY CONTACT KAPLAN FOX?

Kaplan Fox & Kilsheimer LLP is a nationally recognized law firm focused on complex litigation, with offices in New York, Oakland, Los Angeles, Chicago, and New Jersey. Founded in 1956, the firm has spent more than 50 years prosecuting securities, antitrust, and consumer protection actions in federal and state courts nationwide, recovering more than $10 billion for clients and the classes it has represented.

Kaplan Fox is widely regarded as one of the nation’s premier plaintiffs’ securities litigation firms and has received recognition from Chambers and Partners, Benchmark Litigation, Super Lawyers, and Lawdragon. Serving as lead or co-lead counsel in many landmark cases, the firm has secured some of the largest recoveries in the history of securities litigation, including a $2.425 billion recovery on behalf of Bank of America shareholders in In re Bank of America—the largest recovery ever obtained for claims under Section 14(a) of the Securities Exchange Act—$800 million recovered for the Arkansas Teacher Retirement System and other pension funds in ATRS v. Allianz Global Investors, and a $475 million settlement in In re Merrill Lynch.

For decades, Kaplan Fox has represented public pension funds, institutional investors, businesses, and individuals in high-stakes litigation. Through its successful advocacy and precedent-setting victories, the firm has helped shape important areas of securities and corporate law while advancing accountability and protecting investor interests.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Past results do not guarantee future outcomes.

If you have any questions about this Notice, your rights, or your interests, please contact:

CONTACT:

Pamela A. Mayer
KAPLAN FOX & KILSHEIMER LLP
800 Third Avenue, 38th Floor
New York, New York 10022
(646) 315-9003
[email protected]

Laurence D. King
KAPLAN FOX & KILSHEIMER LLP
1999 Harrison Street, Suite 1501
Oakland, California 94612
(415) 772-4704
[email protected]

Contacting or submitting information to Kaplan Fox & Kilsheimer LLP does not create an attorney-client relationship, nor an obligation on the part of Kaplan Fox to retain you as a client.

https://www.kaplanfox.com/case/futu-holdings-limited-class-action-alert-learn-more-now/



Kaplan Fox Urges Hub Group, Inc. (NASDAQ: HUBG) Investors to Contact the Firm Before the Deadline on August 28, 2026

NEW YORK, Aug. 14, 2026 (GLOBE NEWSWIRE) — Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hub Group, Inc. (“Hub Group” or the “Company”) (NASDAQ: HUBG) on behalf of investors that purchased or otherwise acquired Hub Group securities between April 28, 2023 and May 11, 2026 (the “Class Period”).

CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION

If you are an investor in Hub Group and have suffered losses, you may

CLICK HERE

to contact us. You may also contact Kaplan Fox by emailing

[email protected]

or by calling (646) 315-9003.

DEADLINE REMINDER: If you are a member of the proposed Class, you may move the court no later than August 28, 2026 to serve as a lead plaintiff for the purported class. If you have losses we encourage you to contact us to learn more about the lead plaintiff process. You need not seek to become a lead plaintiff in order to share in any possible recovery.

On February 5, 2026, Hub Group announced preliminary fourth quarter and full year 2025 results and disclosed the identification of a $77 million accounting error due to “the understatement of purchased transportation costs and accounts payable in the first nine months of 2025.” Additionally, the Company said it “plans to restate its financial statements for the first, second and third quarters of 2025,” and “is continuing to assess the potential impact to its consolidated financial statements for the years ended December 31, 2024 and 2023.”

On this news, the price of Hub Group stock fell $9.37 per share, or 18.25%, to close at $41.96 per share on February 6, 2026.

Then, on May 12, 2026, Hub Group announced that it had “identified certain transactions that were prematurely or incorrectly recognized or not adequately supported,” causing its 2023 and 2024 annual reports filed with the SEC to be “materially misstated,” such that they “should no longer be relied upon.” The Company did not quantify the expected misstatement, although it stated that it “expects to conclude that it did not maintain effective disclosure controls and procedures and internal control over financial reporting for each of the years ended December 31, 2024 and 2023.”

On this news, the price of Hub Group stock fell $5.24 per share, about 12.5%, to close at $36.62 per share on May 12, 2026.

The complaint alleges, among other things, that throughout the Class Period, the Company’s financial statements contained material misstatements caused by the premature and incorrect recognition of certain transactions and other material misstatements caused by the understatement of purchased transportation costs and accounts payable.

WHY CONTACT KAPLAN FOX?

Kaplan Fox & Kilsheimer LLP is a nationally recognized law firm focused on complex litigation, with offices in New York, Oakland, Los Angeles, Chicago, and New Jersey. Founded in 1956, the firm has spent more than 50 years prosecuting securities, antitrust, and consumer protection actions in federal and state courts nationwide, recovering more than $10 billion for clients and the classes it has represented.

Kaplan Fox is widely regarded as one of the nation’s premier plaintiffs’ securities litigation firms and has received recognition from Chambers and Partners, Benchmark Litigation, Super Lawyers, and Lawdragon. Serving as lead or co-lead counsel in many landmark cases, the firm has secured some of the largest recoveries in the history of securities litigation, including a $2.425 billion recovery on behalf of Bank of America shareholders in In re Bank of America—the largest recovery ever obtained for claims under Section 14(a) of the Securities Exchange Act—$800 million recovered for the Arkansas Teacher Retirement System and other pension funds in ATRS v. Allianz Global Investors, and a $475 million settlement in In re Merrill Lynch.

For decades, Kaplan Fox has represented public pension funds, institutional investors, businesses, and individuals in high-stakes litigation. Through its successful advocacy and precedent-setting victories, the firm has helped shape important areas of securities and corporate law while advancing accountability and protecting investor interests.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Past results do not guarantee future outcomes.

If you have any questions about this Notice, your rights, or your interests, please contact:

CONTACT:

Pamela A. Mayer
KAPLAN FOX & KILSHEIMER LLP
800 Third Avenue, 38th Floor
New York, New York 10022
(646) 315-9003
[email protected]

Laurence D. King
KAPLAN FOX & KILSHEIMER LLP
1999 Harrison Street, Suite 1501
Oakland, California 94612
(415) 772-4704
[email protected]

Contacting or submitting information to Kaplan Fox & Kilsheimer LLP does not create an attorney-client relationship, nor an obligation on the part of Kaplan Fox to retain you as a client.

https://www.kaplanfox.com/case/hub-group-inc/



AppFolio Names Amazon Web Services its Preferred Cloud Provider

The AppFolio Performance Platform runs on AWS, providing the technical foundation for its AI-native architecture and Realm, its AI suite

SANTA BARBARA, Calif., Aug. 14, 2026 (GLOBE NEWSWIRE) — AppFolio (NASDAQ:APPF), the technology leader powering the future of the real estate industry, today announced it has named Amazon Web Services, Inc. (AWS) as its preferred cloud provider.

The AppFolio Performance Platform — its systems of record, action, and growth, along with its AI-native architecture and AppFolio Realm, its full suite of AI capabilities — runs on AWS, giving its nearly 23,000 customers confidence in the reliability, security, and continued innovation their businesses demand.

The infrastructure behind real estate performance


AppFolio’s Performance Ecosystem Report
shows the average property management leader spends two-thirds of their time on reactive, routine work. It’s one sign of the Property Performance Gap, and closing it requires AI that understands real estate from the ground up.

The AI-native architecture of AppFolio is built on four layers:

  • Domain logic encodes the rules and relationships of real estate directly into the platform
  • A data model connects everything across a customer’s business in one unified model
  • Business context mirrors each operator’s SOPs, agreements, and transaction history
  • Governance keeps every AI within operator permissions and compliance policies


AppFolio and AWS collaborate closely on feature development — not just on individual services, but on how those services come together to deliver new AppFolio products. The AppFolio data model runs on Express Brokers for Amazon MSK, the high-throughput messaging infrastructure behind every AI action. As an early adopter, AppFolio worked directly with AWS to shape the product to its performance standards, a collaboration that has strengthened platform reliability and expanded AppFolio’s ability to manage data across its customers’ real estate portfolios.

Real performance, at scale

AppFolio customers are already benefiting through better results. More than 99% are now using some part of AppFolio Realm. Within Realm, Realm-X delivers the platform’s agentic AI capabilities — including Realm-X Performers, which handle the major domains of property management under human monitoring and supervision, and Realm-X Flows, the orchestration layer that routes and automates work.

Amazon Bedrock plays a central role in how AppFolio delivers Realm-X responsibly at scale, providing the governance, safety, and compliance controls the platform requires. Bedrock also gives AppFolio access to the industry’s leading foundation models, with the flexibility to evaluate, adopt, and switch between state-of-the-art AI as it evolves, without rebuilding the platform to do it. That’s how AppFolio stays at the frontier of what AI can do for real estate. Anthropic’s Claude is one example: AppFolio’s use of Claude on Amazon Bedrock is detailed in a published case study.

“The AppFolio Performance Platform is built to close the Property Performance Gap,” said Matthew Baird, Chief Technology Officer, AppFolio. “Our AI-native architecture, our unified data model, our ability to deliver Realm-X responsibly at scale — all of it runs on AWS. Naming AWS our preferred cloud provider reflects how deeply that infrastructure is embedded in what we’re building and where we’re going.”

“AppFolio’s AI-native platform is transforming how property managers run their businesses every day,” said Rich Geraffo, Vice President and Managing Director, AWS North America. “AWS is proud to provide the cloud foundation that helps AppFolio push the boundaries of what agentic AI can do for an entire industry, with the reliability and governance their customers expect.”

About AppFolio
AppFolio is the technology leader powering the future of the real estate industry. Our innovative performance platform and trusted partnership enable our customers to connect communities, increase operational efficiency, and grow their business. For more information about AppFolio, visit appfolio.com.

Media Contact:

[email protected]